Likarda, Inc.

Likarda, Inc. company information, Employees & Contact Information

Explore related pages

Related company profiles:

Likarda is a biotech company developing enabling technologies to transform the way cell therapies are delivered and optimized. Our revolutionary method to coat cells with stealth hydrogels, called Core Shell Spherification® (CSS), protects cells from destruction, keeping them viable while maintaining them in the intended location within the body. Unlike our competitors, Likarda has developed a library of over 50 different hydrogel formulations that work with Core Shell Spherification®, resulting in the ability to uniquely tailor the coating molecules to the specific requirements of the therapeutic cells themselves. From durable and long-term coatings to degradable coatings that deliver cells over days, weeks, or months, we can create exclusive hydrogel formulations tailored for each therapeutic application. Likarda is the remarkable culmination of visionary leadership, science that is just as artistic as academic, and a compelling urge to do what’s right. As we move forward, we have well-defined, long-range goals with added opportunities for flexibility and growth.

Company Details

Employees
14
Founded
-
Address
10330 Hickman Mills Dr, Kansas City,missouri,united States
Phone
(913)945-8241
Email
in****@****rda.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Kansas City, Missouri
Looking for a particular Likarda, Inc. employee's phone or email?

Likarda, Inc. Questions

News

Likarda Announces Core Shell Spherification for Large Molecule Biologics and Welcomes New CEO, Dr. Stella Vnook - Business Wire

Likarda Announces Core Shell Spherification for Large Molecule Biologics and Welcomes New CEO, Dr. Stella Vnook Business Wire

Likarda Receives Gates Foundation Grant to Support its Core-Shell Spherification System - Contract Pharma

Likarda Receives Gates Foundation Grant to Support its Core-Shell Spherification System Contract Pharma

Gates Foundation taps Kansas City biotech Likarda for HIV treatment research - The Business Journals

Gates Foundation taps Kansas City biotech Likarda for HIV treatment research The Business Journals

Women in STEM with Stella Vnook - Drug Target Review

Women in STEM with Stella Vnook Drug Target Review

Crisis as catalyst: From Chernobyl evacuation to biotech innovation - BioXconomy

Crisis as catalyst: From Chernobyl evacuation to biotech innovation BioXconomy

Likarda, CCT announce deal for cell therapy material transportation - STAT Times

Likarda, CCT announce deal for cell therapy material transportation STAT Times

Characterization of Hydrogel Carriers: Improving the Efficacy of Existing Cell Therapies - BioProcess International

Characterization of Hydrogel Carriers: Improving the Efficacy of Existing Cell Therapies BioProcess International

Likarda and eQcell Announce License Option Agreement - Business Wire

Likarda and eQcell Announce License Option Agreement Business Wire

Likarda scaling up biotech research firm with $4M angel boost, new lab - Startland News

Likarda scaling up biotech research firm with $4M angel boost, new lab Startland News

Top Likarda, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant